{
    "clinical_study": {
        "@rank": "146281", 
        "brief_summary": {
            "textblock": "The investigators are testing a novel surgical device to facilitate safe circumcision among\n      adult males.  The investigators hypothesize that this device will allow non-medical\n      providers to perform safe surgical circumcision without adverse events."
        }, 
        "brief_title": "Pilot Trial of Novel Circumcision Device", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Safe Circumcision", 
        "detailed_description": {
            "textblock": "Objective:  To conduct a proof-of-concept study to determine the potential utility of a\n      novel, adjustable single-visit, disposable device to facilitate rapid adult circumcision.\n\n      Design:   Prospective pilot trial of a novel surgical device Setting:   Tertiary care\n      Veterans Administration medical center Patients: 5 adult males Interventions:  Circumcisions\n      performed by junior trainees using an adjustable, single-size surgical-assist device\n      constructed by the University of Washington Applied Physics Laboratory.\n\n      Main Outcome Measure(s):  The attending surgeon and trainees completed standardized forms\n      after each procedure to assess technical problems and ease of use. Follow-up visits were\n      scheduled to evaluate adverse events, post-operative pain, cosmetic outcomes and participant\n      satisfaction at 3, 8, 30 and 90 days post-operatively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion\n\n          1. Uncircumcised males\n\n          2. Aged>18\n\n          3. Sexually active\n\n          4. No plans for moving in next 6 months\n\n          5. Consent to participate\n\n        Exclusion\n\n          1. History of a bleeding disorder\n\n          2. History of a documented concurrent STI of appearance of an STI on initial physical\n             exam\n\n          3. Keloid formation or other condition that might unduly increase risk of elective\n             surgery\n\n          4. Asprin, anti-coagulants or other clinical contra-indications"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885286", 
            "org_study_id": "VAPSHCS-00434"
        }, 
        "intervention": {
            "description": "Circumcision performed with the device in the operating room using local anesthesia", 
            "intervention_name": "circumcision with simple circumcision device", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "circumcision", 
            "HIV prevention"
        ], 
        "lastchanged_date": "June 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98108"
                }, 
                "name": "Veterans Administration Puget Sound Health Care System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Simple Circumcision Device: Proof-of-Concept for a Single-visit, Adjustable Device to Facilitate Safe Adult Male Circumcision", 
        "overall_official": [
            {
                "affiliation": "University of Washington/Seattle Puget Sound VA Health Care System", 
                "last_name": "John N Krieger, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Washington", 
                "last_name": "James M Hotaling, MD MS", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To determine if the novel surgical device was able to facilitate safe circumcision among adult males.  Specifically we looked at:  time of surgery, blood loss, ease of use, cosmetic outcome, number of sutures required, need for conversion to another method of circumcision and need for revision surgeries.", 
            "measure": "Efficacy, injury rate, conversion to standard method rate and cosmetic outcomes of novel surgical device", 
            "safety_issue": "Yes", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885286"
        }, 
        "responsible_party": {
            "investigator_affiliation": "VA Puget Sound Health Care System", 
            "investigator_full_name": "John Krieger", 
            "investigator_title": "Professor of Urology, University of Washington, Section chief Seattle VA urology division", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "To determine how long the operative procedure required to complete", 
            "measure": "Time of circumcision", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "VA Puget Sound Health Care System", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Washington", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "VA Puget Sound Health Care System", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}